Aptamer Group plc has announced the successful adaptation of the Optimer-based test for Alzheimer’s disease into an Enzyme-Linked Immunosorbent...
Read morePteroDynamics received a $7M contract to develop its new drone model, the XP5, for the US Navy. The 19-foot-wide...
Read moreNanoClear Technologies proudly announces that it has secured a worldwide exclusive license for Atomic Layer Polishing (ALP) from the...
Read moreAvvio Medical, Inc. announced the successful treatment of the first patients using its investigational Enhanced Lithotripsy System (ELS), a...
Read moreClearsense announced today it has once again achieved Validated Data Stream status in the National Committee for Quality Assurance (NCQA)...
Read moreGuRu Wireless will be showcasing their infinite flight drone technology at SOF Week 2025 in Tampa, Florida. Read more here.
Read moreActuate Therapeutics, Inc. (NASDAQ: ACTU) announced that Daniel Schmitt, President & Chief Executive Officer of Actuate will present at...
Read moreThe future of drug development is changing, and Vivodyne is helping lead the way. With the FDA’s new push...
Read moreGuRu Wireless, Inc. announced it will participate in Apex Defense 2025, the event that provides a platform for U.S....
Read moreActuate Therapeutics, Inc. (NASDAQ: ACTU), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat...
Read more